Home NDC 59572-984 ISTODAX
Product NDC 59572-984
11-digit product format 595720984
Labeler code 59572
Product ID 59572-984_0a903782-0d58-4078-8486-5fa459dc23b9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name romidepsin
Dosage form KIT
Labeler Celgene Corporation
Application NDA022393
Marketing category NDA
Marketing start 2010-01-04
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022393-001 ISTODAX ROMIDEPSIN 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022393-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS RLD, RS 2009-11-05 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022393-001 ISTODAX 10MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2009-11-05 3a93d1ddd44b…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N022393-001 7608280 2021-08-22 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022393-001 7611724 2021-08-22 Drug substance 74a2ff9319b5…2021-12-28 21:50 UTC 2021-12 N022393-001 7608280 2021-08-22 Drug substance 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N022393-001 7611724 2021-08-22 Drug substance 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022393-001 7608280 2021-08-22 Drug substance 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022393-001 7611724 2021-08-22 Drug substance 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022393-001 7608280 2021-08-22 Drug substance 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N022393-001 7611724 2021-08-22 Drug substance 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022393-001 7608280 2021-08-22 Drug substance 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022393-001 7611724 2021-08-22 Drug substance 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022393-001 7608280 2021-08-22 Drug substance c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N022393-001 7611724 2021-08-22 Drug substance c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022393-001 7608280 2021-08-22 Drug substance 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022393-001 7611724 2021-08-22 Drug substance 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022393-001 7608280 2021-08-22 Drug substance b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022393-001 7611724 2021-08-22 Drug substance b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022393-001 7608280 2021-08-22 Drug substance ea99ee380514…2019-07-19 19:46 UTC 2019-07 N022393-001 7611724 2021-08-22 Drug substance ea99ee380514…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base ISTODAX
Listing expiration 2027-12-31 DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59572-962-10 ISTODAX 2.2 mL in 1 VIAL, GLASS INJECTION, POWDER, LYOPHILIZED, 2.2 mL 10 mg in 2mL 21 59572-984-01 ISTODAX 1 in 1 CARTON KIT 1 21
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59572-984 ISTODAX (ROMIDEPSIN) KIT [CELGENE CORPORATION] 21 Current NDC, Legacy NDC, 2 package rows 20230603_03b39d40-90fe-11df-9de6-0002a5d5c51b.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 59572-962-10 59572096210 2.2 mL in 1 VIAL, GLASS 2.2 ml Historical 59572-984-01 59572098401 1 KIT in 1 CARTON (59572-984-01) * 2.2 mL in 1 VIAL, GLASS (59572-962-10) * 2.4 mL in 1 VIAL, GLASS (59572-973-02) 1 kit 2010-01-04 0000-00-00 No No Current